Carregant...
Donor IFNL4 genotype predicts non-relapse mortality after unrelated donor myeloablative hematopoietic cell transplantation for acute leukemia: A retrospective cohort study
BACKGROUND. IFNL4 genotype regulates the immune response by controlling the production of IFN-λ4, a type III interferon. We hypothesized that IFN-λ4 may play a role in infection clearance or alloreactivity in patients with acute leukemia who received myeloablative 10/10 HLA-matched hematopoietic cel...
Guardat en:
| Publicat a: | Lancet Haematol |
|---|---|
| Autors principals: | , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7735535/ https://ncbi.nlm.nih.gov/pubmed/32976751 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-3026(20)30294-5 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|